Drugs / CBD-bFGF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04233892 | Apr 2020 → Dec 2022 | female infertility of uterine origin | Yali Hu | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD-bFGF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04233892 ↗ |
| Modality | Protein / enzyme biologic | “growth factor therapy” NCT04233892 ↗ |
| Route | Other | “injected into the endometrium” NCT04233892 ↗ |